1. Introduction {#s0005}
===============

The recessive *cw* mouse mutation---named "curly whiskers" to highlight the most obvious mutant phenotype it controls---was discovered in 1958 in a subline of CBA/Cbi mice at the Chester Beatty Research Institute (London, UK), and its linkage with short ear (*Bmp5*) on Chromosome (Chr) 9 was first reported by Falconer and Isaacson \[[@bb0055],[@bb0060]\]. The strongly curled vibrissae in mutants (see [Fig. 1](#f0005){ref-type="fig"}) are easily scored soon after birth, and persist throughout the life span. In 1967, Lyon and Butler \[[@bb0105]\] located *cw* very near the centromere on Chr 9, but this spontaneous variant has not been assigned to any causative gene. A distinct recessive mutation, initially named "tail hair depletion" (abbreviated *thd*), was reported by Les and Roths \[[@bb0100]\] to affect hair development in homozygotes while also generating a dominant, gain-type barrier to tail-skin graft compatibility. Mice carrying the *thd* mutation are now extinct, but while still extant this mutation was found (in a standard complementation test conducted by Roths) to be an allele of *cw*, and was renamed *cw*^*thd*^ in 1978.Fig. 1The mutant curly whiskers phenotype. (A) A 25-day old CWD/LeJ mouse, homozygous for the *cw* mutation, and (B) a close-up of the mutant vibrissae.Fig. 1

These mutant phenotypes suggest that the gene identified by *cw* alleles must play important roles in both hair-follicle development and in histocompatibility. However, a detailed analysis of this pleiotropic locus has long been hampered by a lack of molecular probes that might allow interrogation of this gene\'s normal (and disrupted) structure and function. Here we have taken a positional-candidate approach \[[@bb0030]\] toward making such probes available. As a basis for this effort, we genetically mapped the original *cw* mutation to a very small interval on mouse Chr 9, where only three skin-expressed genes are also located. Next, DNA sequence analysis of one of those candidate genes in mice homozygous for *cw* or for a second, spontaneous, re-mutation to curly whiskers revealed distinct defects that are predicted to impair protein function. Taken together, the evidence we describe strongly suggests that these inherited defects in *Hephl1* (for hephaestin-like 1) are the molecular basis of the developmental and immunogenetic phenotypes displayed by the classical curly-whiskers mutants.

2. Materials and methods {#s0010}
========================

2.1. Mice {#s0015}
---------

Animals were housed and fed according to Federal guidelines, and the Institutional Animal Care and Use Committee (IACUC) at Central Connecticut State University (CCSU) approved of all procedures involving mice (Animal Protocol Applications \#142, \#158, \#162 and \#163). Mice from the standard inbred strains C57BL/6J (JAX Stock \#000664), C57BL/10SnJ (JAX Stock \#000666), and DBA/2J (JAX Stock \#000671); wild-derived, inbred CAST/EiJ mice (JAX Stock \#000928); and inbred CWD/LeJ mice, homozygous for non-agouti (*a*), *cw*, and dilute (*Myo5a*^*d*^)(JAX Stock \#000284) were obtained from The Jackson Laboratory (Bar Harbor, ME, USA). Although CWD/LeJ strain embryos were cryopreserved in 1989 and again in 1999 by crossing *cw Myo5a*^*d*^/*+ Myo5a*^*d*^ with *cw Myo5a*^*d*^/*cw Myo5a*^*d*^, upon its most recent reconstitution in 2015, only *cw*/*cw* offspring were recovered, suggesting that the CWD/LeJ stock no longer segregates for *cw*, *cw*^*+*^.

Twenty-four males of the strain B10.SM *H2*^*v*^ *H2-T18*^*b*^/(70NS)Sn/J (JAX Stock \#000456) were imported to CCSU (after cryo-recovery from liquid nitrogen storage since 1999) in June of 2018. These mice all displayed curly whiskers. In addition, we obtained (from Jane Ober, DNA Resource, The Jackson Laboratory, Bar Harbor, ME) DNA samples isolated from two, independent B10.SM *H2*^*v*^ *H2-T18*^*b*^/(70NS)Sn/J mice that were archived in 1983 (without notation as to their whisker phenotype).

A frozen spleen sample (archived in 1999) from a mouse homozygous for the *cw-Bmp5*^*se*^*-tk* haplotype---descended separately from the same, linkage-tester stock from which the CWD/LeJ line was derived in the 1960\'s---was kindly donated to us by Simon Ball and Rachel Summerfield (MRC Harwell, Oxfordshire, UK).

2.2. DNA isolation and analysis {#s0020}
-------------------------------

Genomic DNA was isolated from two- to three-mm tail-tip biopsies taken from two- to three-week-old mice using Nucleospin® Tissue kits distributed by Clontech Laboratories, Inc. (Mountain View, CA, USA), as directed. The polymerase chain reaction (PCR) was performed in 13 μl reactions using the Titanium PCR kit from Clontech Laboratories, as directed. Oligonucleotide primers for PCR were designed and synthesized by Integrated DNA Technologies, Inc. (Coralville, IA, USA), based on sequence information available online \[[@bb0045],[@bb0145]\]. To score PCR product sizes for microsatellite markers \[[@bb0040]\], reactions plus 2 μl loading buffer were electrophoresed through 3.5% NuSieve® agarose (Lonza, Rockland, ME, USA) gels. Gels were stained with ethidium bromide and photographed under ultraviolet light.

DNA markers based on single nucleotide polymorphisms (SNPs) previously reported to differ between wild-derived CAST and most standard inbred mouse strains \[[@bb0120]\] were also scored. These markers (herein designated *SNP1--5*) are described in detail in [Supplementary Table S1](#ec0025){ref-type="supplementary-material"}, [Supplementary Table S2](#ec0030){ref-type="supplementary-material"}. For DNA sequence analysis, about 1.5 μg of individual PCR amplimers were purified and concentrated into a 30 μl volume using QIAquick® PCR Purification kits (Qiagen Sciences, Germantown, MD, USA) prior to primer-extension sequence analysis performed by the Keck Foundation Resource Laboratory at Yale University (New Haven, CT, USA).

To rapidly determine *cw* and *cw*^*2J*^ genotypes, especially in phenotypically wild type mice, 0.5 μg of individual PCR amplimers were purified and concentrated into a 30 μl volume using QIAquick® PCR Purification kits. For *cw* genotyping we used forward (5′ AAACGTGCTCTGAGATGG 3′) and reverse (5′GTTGCCTTGGAAATAAACTCC 3′) primers that flank the *Hephl1* splice-acceptor defect we describe in the text*.* For *cw*^*2J*^ genotyping we used forward (5′ ATCCAAGGCCTTCTGTTAAGG 3′) and reverse (5′CAGGATGGGACAGACTTTGG 3′) primers that flank *Hephl1*, Exon 14, which contains the single-base insertion we describe in the text. 12 ul samples of the respective purified amplimers were then incubated with 10 units of *Alu*I (for *cw* genotyping) or *Mly*I (for *cw*^*2J*^ typing) (New England BioLabs, Inc.; Ipswich, MA, USA) at 37 °C for 1 h prior to electrophoresis through 3.5% NuSieve® agarose gels at 145 V for 1 h.

2.3. RNA isolation and analysis {#s0025}
-------------------------------

Total RNA was isolated from tail skin samples taken from 1-month-old mutant and control mice using the Nucleospin® RNA Midi kit by Macherey-Nagel (Bethlehem, PA, USA). From these samples, cDNA was generated using the SMARTer® RACE 5′/3′ kit (Clontech Laboratories, Inc.). To detect *Hephl1*-specific sequences, primer pairs that annealed in Exon 9 (5′-ACCTACAGGTGGACAGTGCCAGAAAGC-3′) and Exon 12 (5′-GCTGCTGATCTCATAGATCTGACCCATGCC-3′) were used to direct standard PCR amplifications of these cDNAs. Primers that annealed within Exon 4 of the mouse β actin (*Actb*) gene (5′-CCCAGCCATGACGTAGCCATCCA-3′ and 5′-GAAGCTGTAGCCACGCTCGGTCAG-3′) were used together with *Hephl1* primers to provide an internal loading control. The resulting products were visualized in 3% NuSieve® agarose gels. For primer-extension sequencing, these amplification products were purified and concentrated (as described above) and shipped to the Keck Foundation Resource Laboratory at Yale University.

3. Results {#s0030}
==========

3.1. Genetic mapping of the *cw* mutation on mouse Chr 9 {#s0035}
--------------------------------------------------------

To map the *cw* mutation with respect to molecular markers at the centromeric end of Chr 9, F~1~ heterozygotes made by crossing CWD/LeJ-*cw*/*cw* mice with standard C57BL/6J mice were crossed back to CWD/LeJ mutants, producing 168 offspring. This intraspecific backcross (N~2~) generation segregated for *cw*, dilute (*Myo5a*) and for several PCR-scorable, microsatellite DNA markers \[[@bb0040]\] on Chr 9. [Supplementary Fig. S1](#ec0005){ref-type="supplementary-material"} shows the string of markers transmitted by the F~1~ parent to each of these 168 N~2~ progeny. This haplotype analysis suggested that the *cw* gene must be located about 10% recombination centromeric to *D9Mit64*.

To more precisely locate *cw* in the region between *D9Mit64* and the centromere, a new set of F~1~ heterozygotes was produced by crossing CWD/LeJ to the wild-derived CAST/EiJ strain (since this strain combination offered more microsatellite and single-nucleotide marker dimorphisms than did the CWD/LeJ and C57BL/6J strain-pair), and these *cw*/+ heterozygotes were crossed back to CWD/LeJ mutants. The 994 N~2~ progeny resulting from this inter-subspecific backcross were typed for curly whiskers, dilute pigmentation, and for 10 microsatellite markers on proximal Chr 9, as summarized in [Fig. 2](#f0010){ref-type="fig"}. This haplotype analysis indicated that *cw* must lie between markers *D9Mit61* and *D9Mit60*, and very close to marker *D9Mit220* (which was never meiotically separated from *cw* in this large backcross panel).Fig. 2Segregation of alleles of *cw, Myo5a* (dilute, *d*)*,* and eight dimorphic microsatellite markers among 994 progeny from an inter-subspecific mouse backcross. Heterozygous F~1~ mice (CWD/LeJ x CAST/EiJ) were backcrossed to homozygous CWD/LeJ mutants. The resulting progeny were scored for their fur texture and colour, and a DNA sample from each mouse was typed for the microsatellite markers shown at the left. Only the Chr 9 haplotype inherited from the F~1~ parent is shown (with a knob at the top of the haplotype representing the centromere), and the number of mice inheriting that haplotype is shown below it. Very similar numbers of wild type and mutant progeny---as expected for a testcross (χ^2^ = 1.95, *P* \> .16)---suggest that the mutant phenotype is both fully penetrant and fully viable. The five wild type and the five mutant recombinants marked with an asterisk show that the *cw* locus must lie between *D9Mit61* and *D9Mit60*. *D9Mit220* was not separated from *cw* in this backcross analysis. Genetic distances in percentage recombination are shown to the right (± 1 Standard Error).Fig. 2Fig. 3Physical maps of the *cw*-critical region on mouse Chr 9. (A) The relative positions of three microsatellite (*D9Mit*) markers and five single-nucleotide (*SNP*) markers that closely flank *cw* are shown with a 0.1 Mb scale bar. The eight crossovers that fell centromeric to *cw* (shown in blue, and see [Fig. 2](#f0010){ref-type="fig"}) were localized between *SNP1* and *SNP2*, while the two crossovers that fell telomeric to *cw* (shown in red, and see [Fig. 2](#f0010){ref-type="fig"}) were located between *D9Mit220* and *SNP4*. The extent of 17 known genes that lie in the interval between *D9Mit61* and *D9Mit60* are shown below the line that represents Chr 9. Null alleles of the six genes depicted in brown do not impact hair development in homozygotes. Of the remaining 11 genes, those depicted in blue are not expressed in skin. Because *cw* must be located in the 0.57 Mb interval between *SNP1* and *SNP4*, the skin-expressed genes (*B09Rik*, *Ankrd4*, and *Hephl1*, depicted in green) are most likely to harbor the causative mutation. (B) The *Hephl1* gene is reversed and expanded to show the 20 exons it comprises. Tall green boxes represent coding regions and shorter white boxes represent the untranslated regions. The number below each exon is its length in base pairs. The mutant *Hephl1* allele found in *cw* mice is drawn to show a single-base-pair transition just 5′ to Exon 11 (indicated by the red asterisk) that eliminates a splice acceptor site, resulting in the two variant transcripts diagrammed here (and described further in the text). The mutant *Hephl1* allele found in *cw*^*2J*^ mice is drawn to show the insertion of a single A residue in Exon 14 (at the red dagger), that is predicted to generate an out-of-frame stop codon later in Exon 14 (as described further in the text). (For interpretation of the references to colour in this figure legend, the reader is referred to the web version of this article.)Fig. 3

DNA samples from the ten mice identified as having a crossover between *D9Mit61* and *cw* or between *cw* and *D9Mit60* were typed next for five, single-nucleotide polymorphisms (SNPs) known to lie in the *D9Mit61* to *D9Mit60* interval. These five SNP markers are described in detail in [Supplementary Table S1](#ec0025){ref-type="supplementary-material"}, [Supplementary Table S2](#ec0030){ref-type="supplementary-material"}, and are designated herein as *SNP1--5*. This analysis located the eight crossovers that fell centromeric to *cw* between *SNP1* and *SNP2*, and the two crossovers that fell distal to *cw* between *D9Mit220* and *SNP4* (see [Fig. 3](#f0015){ref-type="fig"}A), thus restricting the possible location of *cw* between *SNP1* and *SNP4* (very near *SNP2*, *SNP3* and *D9Mit220*, which were not meiotically separated from each other or from *cw*).

3.2. Evaluation of *Hephl1* as the possible genetic basis of the *cw* mutation {#s0040}
------------------------------------------------------------------------------

The 0.57 Mb span from *SNP1* to *SNP4* (where the *cw* mutation must lie) includes ten expressed genes ([Fig. 3](#f0015){ref-type="fig"}A). Of these ten, at least six (*Piwil4*, *Fut4*, *Mre11a*, *Gpr83*, *Izumo1r* and *Panx1*) have been knocked out genetically with no reported effect on hair morphology (\[[@bb0010],[@bb0015],[@bb0070],[@bb0075],[@bb0160],[@bb0165]\], respectively), making them unlikely to harbor a mutation that causes the curly-whiskers mutant phenotype. Of the remaining four genes, only three (*1700012B09Rik*, *Ankrd49* and *Hephl1*) are known to be expressed in skin \[[@bb0035]\], where the *cw* mutation has its most obvious effect in mouse mutants. Among these three, *Hephl1* \[[@bb0025]\] seemed to us the most likely gene candidate, since: 1) its product is expressed on the cell surface, where Les and Roths \[[@bb0100]\] suggested the histo-antigenic *cw*^*thd*^ gene product should be found; and 2) its product is a copper-dependent ferroxidase, and generalized copper deficiency (as in humans with defects in the Cu^2+^-transporting ATPase, alpha polypeptide gene, *ATP7A*) is known to cause clinical features that include kinky hair \[[@bb0135]\].Fig. 4Comparison of *Hephl1* in wild type and *cw/cw* mutant mice. (A) All coding regions were sequenced in wild type and in *cw*/*cw* mutant genomic DNA, but only a single difference, at the Intron 10--11 to Exon 11 boundary was found. Shown here are nucleotides 9:15076971 to 9:15076921 from reference sequence GRCm38.p6 (EMGS 2019); with intronic sequences in lower case, exonic sequences in upper case. The pyrimidine-rich tract and the 5′-AG-3′ dinucleotide that compose the standard splice-acceptor signal are indicated over the sequence labeled wild type. The A-to-G substitution found in *cw*/*cw* mutants (at position 9:15076948) is indicated by a red asterisk on the sequence labeled *cw*. (B) Total RNA isolated from wild type, homozygous mutant and heterozygous tail skin was copied into cDNA, and PCR amplified using primers that annealed within Exons 9 and 12 of *Hephl1*. The 606 bp length (shown here) and sequence (see Fig. S2A) of the amplimer copied from wild type (*+*/*+*) cDNA was that expected for the normal splicing of Exons 9 through 12. By contrast, amplification of cDNA derived from mutant (*cw*/*cw*) skin yielded two different-sized products, of 581 bp (Variant 1) and 397 bp (Variant 2), in about an equal abundance. These variant, *cw*-specific PCR products were isolated and sequenced, as shown in Fig. S2B and 2C, respectively. Notably, since Variant 1 generates an early stop codon, it is likely to be the target of nonsense-mediated decay \[[@bb0020]\], and so it may be transcribed at an initially higher level than Variant 2. Amplification of *Hephl1* sequences from cDNAs derived from heterozygous (+/*cw*) skin yielded all three product sizes. While the Variant 2 transcript should be stable (since it is predicted to be fully translated), it appears much less abundant than the wild type transcript in the cDNA pool based on heterozygous skin. (For interpretation of the references to colour in this figure legend, the reader is referred to the web version of this article.)Fig. 4

To test this prime candidate further, the genomic DNA sequence of all *Hephl1* coding regions was determined for CWD/LeJ-*cw*/*cw* mutants and for C57BL/6 J control mice. This analysis revealed only a single-base difference in mutants compared to wild type: an A-to-G transition two bases upstream of Exon 11 (see [Fig. 4](#f0020){ref-type="fig"}A). Because this mutation appears to destroy a splice-acceptor signal, we generated cDNA from tail-skin transcripts isolated from *cw*/*cw* and control wild type tail skin, and PCR-amplified *Hephl1* sequences between Exon 9 and Exon 12. As shown in [Fig. 4](#f0020){ref-type="fig"}B, amplification of cDNA from wild-type skin yielded a 606 bp amplimer as expected for the normal splicing of Exons 9 through 12 (and see sequence details in [Supplementary Fig. S2](#ec0010){ref-type="supplementary-material"}A). By contrast, amplification of *Hephl1* sequences from *cw*/*cw* skin-derived cDNA yielded two smaller PCR products of 581 and 393 bp ([Fig. 4](#f0020){ref-type="fig"}B). Primer-extension analysis of the 581 bp splice variant (Variant 1) revealed a novel junction between Exon 10 and a cryptic splice-acceptor site within Exon 11. This truncated Exon 11, designated Exon 11(Δ25), is 25 nucleotides shorter than the standard exon. This aberrant splice is predicted to disrupt the reading frame and alter three amino acids before an out-of-frame stop codon would terminate translation (as shown in [Supplementary Fig. S2](#ec0010){ref-type="supplementary-material"}B). Primer-extension analysis of the 393 bp splice variant (Variant 2) showed Exon 10 joined with Exon 12 (see [Supplementary Fig. S2](#ec0010){ref-type="supplementary-material"}C). The skipping of Exon 11 in this *cw*-specific transcript is predicted to omit 71 amino acids from the mutant protein product but maintain the normal downstream reading frame. The full-length wild-type and two, *cw*-specific, variant *Hephl1* transcripts are diagrammed in [Fig. 3](#f0015){ref-type="fig"}B.

Next, we developed an *Alu*I-sensitivity assay (see [Supplementary Fig. S3](#ec0015){ref-type="supplementary-material"}A) that was used to rapidly screen among 57 mouse strains that are not associated with the *cw* mutation, and found the standard splice-acceptor sequence in all of them. Only one strain, a linkage-tester stock homozygous for the *cw*-*Bmp5*^*se*^-*tk* haplotype (from the MRC Harwell Institute, Oxfordshire, UK), was found to encode the same *Hephl1* DNA defect as the CWD/LeJ strain (see [Supplementary Fig. S3](#ec0015){ref-type="supplementary-material"}B & C).

3.3. Rediscovery and genetic characterization of the *cw^2J^* mutation {#s0045}
----------------------------------------------------------------------

One strain cryopreserved at The Jackson Laboratory, B10.SM *H2*^*v*^ *H2-T18*^*b*^/(70NS)Sn/J (a C57BL/10 strain congenic for a recombinant *H2* haplotype), was described in some records (but not others) as carrying the *cw* mutation. We obtained DNA samples from two independent mice from this strain that were archived in 1983 (without notation as to their whisker phenotype), but these both showed the wild type sequence at the splice-acceptor site 5′ to Exon 11 in *Hephl1* (see [Supplementary Fig. S3](#ec0015){ref-type="supplementary-material"}B & C). To determine whether B10.SM *H2*^*v*^ *H2-T18*^*b*^/(70NS)Sn/J stock that was cryopreserved in 1994 might carry the *cw* mutation, we obtained 24 reconstituted males---which all displayed curly whiskers---and crossed some with known *cw* homozygotes or heterozygotes (see [Table 1](#t0005){ref-type="table"}). The failure of a recessive defect homozygous in the B10.SM *H2*^*v*^ *H2-T18*^*b*^/(70NS)Sn/J strain to complement *cw* (see [Fig. 5](#f0025){ref-type="fig"}) suggests that this defect is an allele of *cw*. Because this congenic strain is unrelated to the original *cw* mutation (and because it lacks the point mutation we have found to be specifically associated with *cw*), we hypothesized that this recessive variant might be a spontaneous re-mutation that we designated "curly whiskers; curly whiskers 2 Jackson", abbreviated *cw*^*2J*^.

Sequence analysis of all 20 coding regions of the *Hephl1* gene in B10.SM *H2*^*v*^ *H2-T18*^*b*^/(70NS)Sn/J-*cw*^*2J*^ mutants revealed just one DNA defect *vs.* C57BL/10SnJ controls: the insertion of a single A residue in Exon 14, codon 820 (see [Fig. 6](#f0030){ref-type="fig"}A). This frameshift mutation is predicted to alter 7 amino acids before an out-of-frame stop codon would terminate translation. While normal-sized *Hephl1* PCR products may be amplified from cDNAs based on transcripts isolated from *cw*^*2J*^/*cw*^*2J*^ mutant tail skin, those products appear less abundant than products amplified from cDNAs derived from wild-type skin (see [Fig. 6](#f0030){ref-type="fig"}B). This observation may indicate that *cw*^*2J*^ mutant transcripts are unstable, consistent with nonsense-mediated decay \[[@bb0020]\]. The full-length *cw*^*2J*^ transcript is diagrammed in [Fig. 3](#f0015){ref-type="fig"}B.Fig. 5Phenotype and genotype of mice from a cross of *+*/*cw* with curly-whiskered B10.SM *H2*^*v*^*H2-T18*^*b*^/(70NS)Sn/J mice (*i.e.*, Cross 4 in [Table 1](#t0005){ref-type="table"}). This cross produced 20 offspring, 13 with straight whiskers and 7 with curly whiskers. The snout of a typical straight-whiskered mouse (A) and a typical curly-whiskered mouse (B) are shown at 2 weeks of age. This result suggests that the mutation that causes hair-curling in the B10.SM *H2*^*v*^*H2-T18*^*b*^/(70NS)Sn/J strain is recessive, and that this mutation is an allele of *cw* that we hereby designate *cw*^*2J*^. (C) To confirm that all non-complementing, mutant offspring from this cross (labeled M) inherited one copy of *cw*, and that the phenotypically wild type offspring (labeled W) inherited a *cw*^*+*^ allele instead, a 203 bp amplimer that included the site of the *Hephl1*, splice-acceptor defect associated with *cw* was produced for each mouse, and tested for sensitivity to *Alu*I digestion. By this assay (see Fig. S2), amplimers derived from *cw* templates are resistant to cleavage, while amplimers based on other templates are cut into 125 and 78 bp fragments.Fig. 5Table 1Initial crosses of curly-whiskered, B10.SM *H2*^*v*^*H2-T18*^*b*^/(70NS)Sn/J males.Table 1CrossFemale partner strain (*cw* genotype)Offspring phenotypeWild typeCurly1C57BL/10 (*+*/*+*)802CWD/LeJ (*cw*/*cw*)0123CWD.D2 (*cw*/*cw*)0194CWD.D2 (*+*/*cw*)137[^1]Fig. 6Comparison of *Hephl1* in wild type and *cw*^*2J*^*/cw*^*2J*^ mutant mice. (A) All coding regions were sequenced in wild type and in *cw*^*2J*^*/cw*^*2J*^ mutant genomic DNA, but only a single difference, in Exon 14, was found. This mutation, the insertion of a single A residue in *cw*^*2J*^*/cw*^*2J*^ mutants compared to wild type, is indicated with a red asterisk on the sequence labeled *cw*^*2J*^*.* The sequence shown here includes nucleotides 9:15067163 to 9:15067125, from reference sequence GRCm38.p6 (EMGS 2019). This insertion is predicted to shift the translational reading frame on mutant transcripts, generating seven novel amino acids (residues 820--826, shown in red) followed by an early, out-of-frame stop codon. (B) Total RNA isolated from wild type, homozygous *cw*^*2J*^*/cw*^*2J*^ mutant or heterozygous tail skin was copied into cDNA, and PCR amplified using one primer pair specific to *Hephl1* together with a second primer pair specific to the β actin gene (*Actb*)*.* The resulting amplimers were then separated by gel electrophoresis. While the levels of *Actb* signal amplified from the cDNAs derived from each different genotype is essentially equivalent, *Hephl1* transcripts amplified from *cw*^*2J*^/*cw*^*2J*^ templates appear markedly less abundant compared to amplimers based on wild type cDNAs. It is likely that this variant transcript, which cannot be fully translated, is unstable due to nonsense-mediated mRNA decay \[[@bb0020]\]. (For interpretation of the references to colour in this figure legend, the reader is referred to the web version of this article.)Fig. 6

Finally, we developed an *Mly*I-sensitivity assay (see [supplementary Fig. S4](#ec0020){ref-type="supplementary-material"}A) to rapidly screen among 60 mouse strains for defects in *Hephl1*, Exon 14, codon 820. The only amplimers resistant to endonuclease treatment (and verified by primer-extension analysis to possess an inserted adenosine residue) were based on our reconstituted B10.SM *H2*^*v*^ *H2-T18*^*b*^/(70NS)Sn/J-*cw*^*2J*^ mice or on the B10.SM *H2*^*v*^ *H2-T18*^*b*^/(70NS)Sn/J DNA samples that were archived in 1983 (see [Supplementary Fig. S4](#ec0020){ref-type="supplementary-material"}B).

4. Discussion {#s0050}
=============

4.1. The mouse *cw* mutations are mutant alleles of *Hephl1* {#s0055}
------------------------------------------------------------

We have taken a positional-candidate approach to assign the classic *cw* mutation in mice to a splice-acceptor defect in the *Hephl1* gene. Our identification of a second, distinct, allele-specific *Hephl1* defect (a frameshift-inducing, single-base insertion) associated with the *cw*^*2J*^ mutation strongly supports this single-gene assignment. We therefore recommend that these curly-whiskers mutations be formally renamed "hephaestin-like 1; curly whiskers" (abbreviated *Hephl1*^*cw*^), and "hephaestin-like 1; curly whiskers 2 Jackson" (abbreviated *Hephl1*^*cw-2J*^). We suggest that the *Hephl1*^*cw-2J*^ mutation occurred spontaneously on the B10.SM *H2*^*v*^ *H2-T18*^*b*^/(70NS)Sn/J background at least by 1983 (since both the archived DNA samples we analyzed are homozygous for the A insertion in Exon 14), and appears to have become fixed in that strain by its initial cryopreservation in 1999 (since all 39 mice reconstituted for us in 2018 displayed curly whiskers).

Because we restricted our DNA-sequence analysis to *Hephl1* coding regions, only, it remains formally possible that the mutant curly-whiskers phenotype could require additional, unidentified defect(s) in the critical region that work in combination with the *Hephl1* defects that we have described. While we think that such a "two-hit" mechanism is highly unlikely, we note that this model will be explicitly tested when mice homozygous for discrete, engineered variants of *Hephl1*, such as have already been produced (see \[[@bb0180],[@bb0155],[@bb0125]\]) or can be generated *de novo* by gene editing, are phenotypically evaluated.

4.2. Structure and function of *Hephl1*, and its mutant isoforms {#s0060}
----------------------------------------------------------------

*Hephl1* encodes one of three muticopper feroxidases (in addition to hephaestin, *Heph*, and ceruloplasmin, *Cp*) that facilitate iron transport in a variety of tissues and display mostly distinct expression patterns in mammals \[[@bb0025]\]. The membrane-bound Hephl1 ferroxidase has 6 cupredoxin domains, with binding sites for 6 copper ions. Three of the copper ions form a trinuclear center at the interface of Domains 1 and 6, while the other three form mononuclear centers, and are organized in Domains 2, 4, and 6. In addition, Domain 6 includes a predicted iron-binding site, and is followed by a transmembrane domain \[[@bb0025]\]. The splice-acceptor defect that we have found associated with *cw* causes omission of Exon 11 from the mature transcript (designated splice Variant 2 in the text), and the resulting mutant Hephl1^cw^ protein is predicted to lack 71 amino acids normally found in Domain 4, but the downstream reading frame is unaltered. By contrast, the frameshifted variants we described (the *Hephl1*^*cw*^-specific splice Variant 1 and the *Hephl1*^*cw-2J*^ transcript), since they encode early stop codons, are likely to be eliminated by nonsense-mediated decay \[[@bb0020]\]. Even if these truncated protein products were produced, they would lack Domains 5 and 6 (including the iron-binding site), and the C-terminal, membrane-spanning domain, and therefore are not expected to contribute any membrane-bound ferroxidase function at all. Hephaestin-like 1\'s role in iron nutrition and homeostasis is not well understood, but our assignment of two, allelic, curly-whiskers mouse mutants to *Hephl1* should help to set-the-stage for the needed molecular and whole-animal studies.

Segregation data shown in Fig. S1 and in [Fig. 2](#f0010){ref-type="fig"} suggest that the *Hephl1*^*cw*^ allele does not negatively impact general viability in homozygotes, at least by weaning age (when our testcross offspring were counted). This may suggest that Hephl1 is not an essential protein, or instead may indicate that the Hephl1^cw^ isoform translated from transcripts that skip Exon 11---despite lacking 71 amino acids in Domain 4---might be normally located in the cell membrane and might retain some "leaky" ferroxidase function. While we have collected only limited segregation data from *Hephl1*^*cw-2J*^ testcrosses, to date, our current tally does show a small deficit of mutants compared to wild type (perhaps indicating that *Hephl1*^*cw-2J*^ may control a more severe phenotype than *Hephl1*^*cw*^), but these counts are still modest (*N* = 106) and the deviation from the 1 wild:1 mutant testcross ratio expected for full viability is not statistically significant (*P* \> .12). Of course, any predictions regarding Hephl1^cw^ and Hephl1^cw-2J^ protein structure, location, and function need to be explicitly tested, ideally, side-by-side with a *bone fide* null mutant, as are readily available from multiple sources (see \[[@bb0180],[@bb0155],[@bb0125]\], for example).

4.3. *Hephl1* impairment causes *pili torti* {#s0065}
--------------------------------------------

Our selection of *Hephl1* as a likely positional candidate for *cw* was largely due to the association of kinky, brittle hair (*pili torti*) with generalized copper deficiency, as in Menkes disease, an X-linked recessive disorder (resulting from defects in the copper-transport protein ATP7A) whose myriad clinical features are thought to result from the dysfunction of several copper-dependent enzymes (OMIM, entry \#309400, \[[@bb0135]\]). While several cuproenzymes have been proposed to account for the various features of the disorder (tyrosinase for depigmentation of hair and skin, lysyl oxidase for connective tissue defects, cytochrome c oxidase for hypothermia, and ascorbate oxidase for skeletal demineralization, for example; reviewed by \[[@bb0115]\]), this report is the first to implicate hephaestin-like 1 in, at least, the kinky-hair feature of Menkes disease and the related occipital horn syndrome (OMIM, entry \#304150, \[[@bb0130]\]). Other aspects of these disease syndromes may also be owing to reduced Hephl1 activity, since *Hephl1* is expressed in some of the same tissues impacted by these conditions (including the retina \[[@bb0085],[@bb0095]\], synovial membranes \[[@bb0005]\], and in the cardiovascular, connective, urinary and nervous systems \[[@bb0025]\]), but these tissues have not yet been examined in any detail in the curly-whiskers mouse mutants. In any case, the animal models we have now causally ascribed to *Hephl1*-deficiency should facilitate the functional dissection of these complex, pleiotropic human disorders, and hopefully advance the development of treatments for at least some aspects of the syndromes they generate.

4.4. Do these curly-whiskers mutants generate skin-graft histoincompatibility? {#s0070}
------------------------------------------------------------------------------

We remain especially curious to learn whether *Hephl1*^*cw*^ and/or *Hephl1*^*cw-2J*^, like the now-extinct *cw*^*thd*^ allele, might also generate an immunological "gain" or "loss" of antigenicity that can be detected by skin-graft-exchange assay, for example. Classically, mutations that create such heritable barriers to graft compatibility have identified the so-called minor histocompatibility (*H*) loci \[[@bb0140]\], which currently number in excess of 60. However, mutations that affect both transplantation acceptance and a distinct developmental function are quite rare. We know of only one other example, the recessive *H*-*mshi* mutation (for "male sterility and histoincompatibility", \[[@bb0185]\]) which causes aspermia in homozygous males, but was initially discovered as the loss of a cell-surface antigen, such that tail skin from +/+ mice is rejected by (otherwise genetically-matched) *mshi*/*mshi* mutants, which recognize the *mshi*^*+*^ antigen as "foreign" \[[@bb0065],[@bb0110],[@bb0150],[@bb0170]\].

This sort of phenotypic complexity interests us for several reasons. First, we anticipate that the antigenicity of the gene product might easily be exploited to provide another molecular "handle" for gaining access to the molecular physiology controlled by *Hephl1*. Second, mutations that control seemingly unrelated functions (histocompatibility and sperm production or hair development, for example), offer an opportunity to dissect the cause of such compelling pleiotropy, a phenomenon of enduring interest in formal genetics. Third, it seems possible (even likely) that the study of antigen-altering mutations could reveal much about human disease phenotypes that might involve auto-immune reactions against the orthologous protein products (see \[[@bb0080]\]). Finally, we believe it is still important to identify and characterize new minor *H* loci, so that their individual and collective significance in graft transplantation can be formally assessed.

To prepare to conduct such histogenic assessments, we have been developing genetically "pure" mouse stocks that segregate for *Hephl1*^*+*^ and each recessive curly-whiskers mutation. These inbred strains should allow the production of homozygous mutant, heterozygous, and homozygous wild-type subjects on the otherwise uniform genetic background that is required for single-gene, allograft analysis. To develop a line that segregates for *Hephl1*^*+*^ and *Hephl1*^*cw*^, we have crossed CWD/LeJ homozygotes, *Hephl1*^*cw*^ *Myo5a*^*d*^/*Hephl1*^*cw*^ *Myo5a*^*d*^, with strain DBA/2J (the original source of the *Myo5a*^*d*^ in the CWD/LeJ strain). The resulting *Hephl1*^*+*^ *Myo5a*^*d*^/ *Hephl1*^*cw*^ *Myo5a*^*d*^ F~1~ offspring (with straight vibrissae) were then crossed back to CWD/LeJ mutants to produce *Hephl1*^*cw*^/*Hephl1*^*+*^ heterozygotes that were crossed back to CWD/LeJ, and so on. This segregating congenic line, named CWD.D2-*Hephl1*^*+*^/*Hephl1*^*cw*^*,* is currently at N~13~. To develop a stock segregating for *Hephl1*^*+*^ and *Hephl1*^*cw-2J*^, we crossed B10.SM *H2*^*v*^ *H2-T18*^*b*^/(70NS)Sn/J-*Hephl1*^*cw-2J*^ mutant males to C57BL/10SnJ females, and the F~1~ offspring were crossed back to C57BL/10SnJ. Heterozygous offspring from this cross, identified by the *Mly*I-sensitivity test we described, were crossed back to C57BL/10SnJ, and so on, to create a segregating inbred strain named C57BL/10SnJ-*Hephl1*^*+*^/*Hephl1*^*cw-2J*^ (currently at N~5~) that will be, essentially, co-isogenic. While primarily designed for the immunogenetic analyses that we anticipate performing, these uniform, inbred stocks should also be ideal for making other well-controlled molecular and functional comparisons among the various *Hephl1* genotypes.

4.5. Positional cloning: the end of an era {#s0075}
------------------------------------------

In recent years, modern methods (like whole-genome DNA sequencing) have supplanted positional cloning (sometimes called "reverse genetics") as an approach for making causative-gene assignments for spontaneous mutations, in both mice and man \[[@bb0050],[@bb0090],[@bb0175]\]. And even if this powerful new method works best when the natural variant under study has had some prior positional characterization, genetic mapping as a means to gain initial access to gene structure and function appears (perhaps with this report) to have become outdated. Indeed, the current ease with which genetic variants can be deliberately and precisely engineered (by gene targeting or gene editing, for example), infers that even spontaneous mutations---once the *only* source genetic variation---are no longer particularly prized. We would argue, instead, that natural mouse variants (like curly whiskers) often contribute a critically informative part of an allelic series, where they can frequently offer a unique perspective into the pathobiology of inherited human disorders, which similarly result from leaky, pleiotropic and often surprising spontaneous mutations.

The following are the supplementary data related to this article.Supplementary Fig. S1Segregation of alleles of *cw, Myo5a* (dilute)*,* and four dimorphic microsatellite markers among 168 progeny from an intraspecific mouse backcross. Heterozygous F~1~ mice (CWD/LeJ x C57BL/6 J) were backcrossed to homozygous CWD/LeJ mutants. The resulting progeny were scored for their fur texture and colour, and a DNA sample from each mouse was typed for the microsatellite markers shown at the left. Only the Chr 9 haplotype inherited from the F~1~ parent is shown (with a knob at the top of the haplotype representing the centromere), and the number of mice inheriting that haplotype is shown below it. Very similar numbers of wild and mutant progeny---as expected for a testcross (χ^2^ = 0.024, *P* \> .87)---suggest that the mutant phenotype is both fully penetrant and fully viable. The 11 wild type recombinants and the 6 mutant recombinants marked with an asterisk show that the *cw* locus must lie centromeric to *D9Mit64*. Genetic distances in percentage recombination are shown to the right (± 1 Standard Error).Supplementary Figure S1Supplementary Fig. S2Exon/exon junctions for the *Hephl1* PCR products that were amplified from cDNA pools based on wild type or *cw*/*cw* mutant skin. PCR products shown in [Fig. 4](#f0020){ref-type="fig"}B were isolated and subjected to primer-extension sequence analysis. (A) The 606 bp amplimer based on wild type cDNA demonstrated normal splicing of Exons 9 through 12 (only the Exon 10/11 and Exon 11/12 junctions are shown). (B) The 581 bp product, designated Splice Variant 1, includes the unusual junction shown, with Exon 10 joined to Exon 11(Δ25), which is 25 nucleotides shorter than the standard Exon 11. The *cw*-specific Exon 11(Δ25) seems to be defined by a cryptic splice-acceptor site composed of the polypyrimidine tract at the 3′ end of Intron 10--11 and the first 5′-AG-3′ dinucleotide within Exon 11 (shown underlined in blue in [Fig. 4](#f0020){ref-type="fig"}A). The Variant 1 transcript is predicted to disrupt the normal reading frame, introducing 3 novel amino acids (numbered 623--625, shown in red) followed by an out-of-frame stop codon. It is likely that this variant transcript, which cannot be fully translated, will be unstable due to nonsense-mediated mRNA decay \[[@bb0020]\]. (C) The 393 bp product, designated Splice Variant 2, is the result of Exon 10 joining with Exon 12. The skipping of Exon 11, which measures 213 nucleotides, generates a variant transcript that can be fully translated, and is predicted to yield a mutant protein product that lacks 71 (of the usual 1159) amino acids.Supplementary Figure S2Supplementary Fig. S3A splice-acceptor defect located 5′ of Exon 11 in the *Hephl1* gene is specific to the *cw* mutation in mice. (A) The rationale of an *Alu*I-sensitivity test for rapid detection of mutation at the splice acceptor site 5′ of Exon 11 in the *Hephl1* gene is shown. The sequence displayed here includes nucleotides 9:15077024 to 9:15076822, from reference sequence GRCm38.p6 \[[@bb0045]\]. Lower-case sequences are from Intron 10--11; sequences in capital letters are from Exon 11. An *Alu*I, restriction endonuclease target sequence is highlighted in yellow, and a red arrow shows the position of the cleavage site. The primers used to direct amplification of the 203 bp sequence shown are underlined. *Alu*I digestion will yield two fragments of 78 + 125 = 203 bp for amplimers based on wild-type templates. Amplimers that carry any disruption of the *Alu*I target sequence (for example, the A to G transition we have found in *cw* mutants) will be resistant to *Alu*I digestion. (B) Typical results of *Alu*I-sensitivity testing among various inbred mouse strains. PCR-generated amplimers based on genomic DNA templates were incubated with *Alu*I, and electrophoresed through 3.5% NuSieve agarose. The only amplimers fully resistant to cutting were based on CWD/LeJ and STOCK *cw*-*Bmp5*^*se*^-*tk*/H (marked with a red dagger) templates, strains known to be homozygous for *cw*. Three known *cw* carriers (backcross generations N~2~, N~8~, and N~10~) show both *Alu*I-resistant and sensitive digestion products. The lane marked with a red asterisk contains an *Alu*I-sensitive amplimer copied from the B10.SM *H2*^*v*^*H2-T18*^*b*^/(70NS)Sn/J strain (which has phenotypically curly whiskers) indicating a normal DNA sequence at this site. (C) DNA sequence of B10.SM *H2*^*v*^*H2-T18*^*b*^/(70NS)Sn/J and STOCK *cw*-*Bmp5*^*se*^-*tk*/H genomic DNA near the splice acceptor site 5′ to Exon 11 in the mouse *Hephl1* gene. A black arrow indicates the position which has mutated to a G in the CWD/LeJ-*cw*/*cw* strain (position 9:15076948, from reference sequence GRCm38.p6; EMGS \[[@bb0045]\]). Consistent with the results of *Alu*I-sensitivity testing, STOCK *cw*-*Bmp5*^*se*^-*tk*/H shows the same defect as CWD/LeJ, whereas B10.SM *H2*^*v*^*H2-T18*^*b*^/(70NS)Sn/J strain has no defect at this position.Supplementary Figure S3Supplementary Fig. S4Insertion of a single A residue in Exon 14 of the *Hephl1* gene is specific to the *cw*^*2J*^ mutation in mice. (A) The rationale of an *Mly*I-sensitivity test for rapid detection of mutation at codon number 820 of the *Hephl1* gene is shown. The sequence displayed here includes nucleotides 9:15067278 to 9:15067007, from reference sequence GRCm38.p6 (EMGS \[[@bb0045]\]). Sequences in capital letters are Exon 14; lower-case sequences are from the flanking introns. Two *Mly*I restriction endonuclease target sequences are highlighted in yellow, and red arrows show the positions of the respective cleavage sites. The primers used to direct amplification of the 272--273 bp sequence shown are underlined. *Mly*I digestion will yield three fragments of 69 + 81 + 122 = 272 bp for amplimers based on the wild type sequence. Amplimers that encode a disruption of the 5′ *Mly*I target sequence (for example, the A insertion we have found in *cw*^*2J*^ mutants) will cut only at the 3′ *Mly*I target site, yielding an 81 bp and a longer fragment (*e.g.*, 192 bp for a single-base-pair insertion). (B) Typical results of *Mly*I-sensitivity testing among various inbred mouse strains. PCR-generated amplimers based on genomic DNA templates were incubated with *Mly*I, and electrophoresed through 3.5% NuSieve® agarose. Only amplimers based on *cw*^*2J*^/*cw*^*2J*^ or *+*/ *cw*^*2J*^ templates showed the *Mly*I-resistant 192 bp band.Supplementary Figure S4Supplementary Table S1Description of SNP markers referred to in the Eragene *et al.* (2019) text.Supplementary Table S1Supplementary Table S2Location of SNP markers referred to in the Eragene et al. (2019) text.Supplementary Table S2
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[^1]: Males of the B10.SM *H2*^*v*^*H2-T18*^*b*^/(70NS)Sn/J strain, all showing curly whiskers, were crossed with female mice, as indicated. The resulting offspring were assessed for their whisker phenotype at weaning. The result of Cross 1 suggests that the mutant hair phenotype displayed by B10.SM males is generated by homozygosity for a recessive mutation. The results of Crosses 2--4 show that this recessive mutation does not complement the *cw* mutation. We therefore designate the recessive mutation that arose on the B10.SM background curly whiskers-2 Jackson, abbreviated *cw*^*2J*^. Typical wild type and mutant pups from Cross 4 are shown in [Fig. 5](#f0025){ref-type="fig"}. The number of wild type and mutant offspring from Cross 4 is not different from the 1:1 ratio expected for a test cross (Χ^2^ = 1.8; *P* \> .17).
